fbpx

Longtime GC of Biotech That Discovered Leading Hep-C Cure Announces Retirement

Nathaniel Gardiner will retire at the end of March 2024, after 28 years with Entata Pharmaceuticals.

       

Related Articles

Responses

Your email address will not be published. Required fields are marked *